Fresenius SE & Co. KGaA (FRA:FREA)
10.30
-0.20 (-1.90%)
Last updated: Aug 1, 2025
Intra-Cellular Therapies Market Cap
Fresenius SE & Co. KGaA has a market cap or net worth of €23.14 billion as of August 1, 2025. Its market cap has increased by 37.15% in one year.
Market Cap
23.14B
Enterprise Value
35.05B
Revenue
22.13B
Ranking
n/a
PE Ratio
54.84
Stock Price
$10.30
Market Cap Chart
Since April 23, 1997, Fresenius SE & Co. KGaA's market cap has increased from 1.90B to 23.14B, an increase of 1,118.11%. That is a compound annual growth rate of 9.24%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 23.64B | 25.16% |
Dec 30, 2024 | 18.89B | 19.49% |
Dec 29, 2023 | 15.81B | 6.93% |
Dec 30, 2022 | 14.78B | -25.21% |
Dec 30, 2021 | 19.77B | -6.28% |
Dec 30, 2020 | 21.09B | -24.56% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 292.08B |
Siemens Aktiengesellschaft | 174.92B |
Deutsche Telekom AG | 153.20B |
Allianz SE | 132.59B |
Siemens Energy AG | 80.60B |
Rheinmetall AG | 79.52B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 74.53B |
Deutsche Bank Aktiengesellschaft | 55.70B |